Evidence map›Paper›PMID 30472260›Full record

ReviewProgress in lipid research2019

Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies.

Nikhlesh K Singh, Gadiparthi N Rao

Abstract readReview
In one paragraph

Review in Progress in lipid research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 206 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
206citing papers in PubMed, 2 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

206 citing papers in PubMed, 2 syntheses or guidelines pooled it, 327 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. WTAP Histone Lactylation Drives the YTHDF1/ALOX15 Axis to Regulate Ferroptosis in Myocardial Ischemia-Reperfusion Injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

146 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nikhlesh K SinghDepartment of Physiology, University of Tennessee Health Science Center, 71 S. Manassas Street Memphis, Memphis, TN 38163, USA.
Gadiparthi N RaoDepartment of Physiology, University of Tennessee Health Science Center, 71 S. Manassas Street Memphis, Memphis, TN 38163, USA. Electronic address: rgadipar@uthsc.edu.
University of Tennessee Health Science Center · US

Funding

Non-COX Arachidonic Acid Metabolites and AngiogenesisR01HL074860 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI RAO, GADIPARTHI N · 2004 to 2020
$5.9M
PLA2, EICOSANOIDS AND VASCULAR REMODELINGR01HL064165 · NHLBI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI RAO, GADIPARTHI N · 2000 to 2016
$5.4M
Phospholipases and retinal angiogenesisR01EY014856 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI RAO, GADIPARTHI N · 2006 to 2021
$5.0M
GPCR Signaling & Vascular Wall RemodelingR01HL103575 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI RAO, GADIPARTHI N · 2011 to 2019
$4.1M
NEI NIH HHS R01 EY014856NHLBI NIH HHS R01 HL064165NHLBI NIH HHS R01 HL074860NHLBI NIH HHS R01 HL103575
6 · The paper itself

Abstract

12/15-lipoxygenase (12/15-LOX) is an enzyme, which oxidizes polyunsaturated fatty acids, particularly omega-6 and -3 fatty acids, to generate a number of bioactive lipid metabolites. A large number of studies have revealed the importance of 12/15-LOX role in oxidative and inflammatory responses. The in vitro studies have demonstrated the ability of 12/15-LOX metabolites in the expression of various genes and production of cytokine related to inflammation and resolution of inflammation. The studies with the use of knockout and transgenic animals for 12/15-LOX have further shown its involvement in the pathogenesis of a variety of human diseases, including cardiovascular, renal, neurological and metabolic disorders. This review summarizes our current knowledge on the role of 12/15-LOX in inflammation and various human diseases.

Indexed as

AnimalsAnimals, Genetically ModifiedArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseDiabetes ComplicationsDisease Models, AnimalFatty Acids, Omega-3Fatty Acids, Omega-6HumansInflammationNervous System DiseasesObesityVascular DiseasesALOX12 protein, humanALOX15 protein, humanArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseFatty Acids, Omega-3Fatty Acids, Omega-6

Identifiers

PMID30472260
PMCPMC6338518
OpenAlexW2901710743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.